Results 1 to 10 of about 2,955,835 (214)
Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source
New England Journal of Medicine, 2018 Background Embolic strokes of undetermined source represent 20% of ischemic strokes and are associated with a high rate of recurrence. Anticoagulant treatment with rivaroxaban, an oral factor Xa inhibitor, may result in a lower risk of recurrent stroke ...
Hardi Mundl +2 more
exaly +2 more sources
Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source
New England Journal of Medicine, 2019 Background Cryptogenic strokes constitute 20 to 30% of ischemic strokes, and most cryptogenic strokes are considered to be embolic and of undetermined source.
Ralph L Sacco +2 more
exaly +2 more sources
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023 Background The COVID‐19 pandemic affected outpatient care delivery and patients' access to health care. However, no prior studies have documented telehealth use among patients with cardiovascular disease.
Jun Soo Lee +3 more
doaj +1 more source
Postgraduate Medical Journal, 1995 Stroke is ideally suited for prevention. It has a high prevalence, burden of illness, and economic cost, and safe and effective prevention measures. The estimated $30 billion that is being spent for stroke each year in the United States should not come as a surprise given the approximately 3 million stroke survivors and 400,000 to 500,000 new or ...
R, Tozer, I R, Hastie
openaire +4 more sources
Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation.
New England Journal of Medicine, 2023 BACKGROUND Subclinical atrial fibrillation is short-lasting and asymptomatic and can usually be detected only by long-term continuous monitoring with pacemakers or defibrillators.
J. Healey +36 more
semanticscholar +1 more source
Social Determinants of Health–Related Z Codes and Health Care Among Patients With Hypertension
AJPM Focus, 2023 Introduction: Tracking social needs can provide information on barriers to controlling hypertension and the need for wraparound services. No recent studies have examined ICD-10-CM social determinants of health–related Z codes (Z55–Z65) to indicate social
Jun Soo Lee, PhD +4 more
doaj +1 more source
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021 Background Amid recently rising heart failure (HF) death rates in the United States, we describe county‐level trends in HF mortality from 1999 to 2018 by racial/ethnic group and sex for ages 35 to 64 years and 65 years and older.
Adam S. Vaughan +4 more
doaj +1 more source
Atrial fibrillation and stroke prevention: 25 years of research at EP Europace journal
Europace, 2023 Stroke prevention in patients with atrial fibrillation (AF) is one pillar of the management of this common arrhythmia. Substantial advances in the epidemiology and associated pathophysiology underlying AF-related stroke and thrombo-embolism are evident ...
G. Lip +10 more
semanticscholar +1 more source
Primary stroke prevention worldwide: translating evidence into action
Lancet Public Health, 2021 Summary Stroke is the second leading cause of death and the third leading cause of disability worldwide and its burden is increasing rapidly in low-income and middle-income countries, many of which are unable to face the challenges it imposes.
M. Owolabi +176 more
semanticscholar +1 more source